Kommentar zu „Nasopharynxkarzinom: künstliche Intelligenz zur Prognosebestimmung“

• Literatur

• 1 Bossi P, Chan AT, Licitra L. et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021; 32: 452-465
• 2 Juarez-Vignon Whaley JJ, Afkhami M, Onyshchenko M. et al. Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?. Curr Treat Options Oncol 2023; 24: 1138-1166
• 3 Guo R, Tang LL, Mao YP. et al. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 2019; 125: 79-89